Agency Forms Undergoing Paperwork Reduction Act Review, 36211-36212 [2020-12806]
Download as PDF
<![CDATA[
36211
Federal Register / Vol. 85, No. 115 / Monday, June 15, 2020 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Average
burden per
response
(min./hour)
Total burden
(hours)
57.402 Outpatient Procedure Component Same Day Outcome Measures ....
57.403 Outpatient Procedure Component—Monthly Denominators for Same
Day Outcome Measures ..............................................................................
57.404 Outpatient Procedure Component—SSI Denominator ........................
57.405 Outpatient Procedure Component—Surgical Site (SSI) Event ...........
57.500 Outpatient Dialysis Center Practices Survey ......................................
57.501 Dialysis Monthly Reporting Plan ..........................................................
57.502 Dialysis Event ......................................................................................
57.503 Denominator for Outpatient Dialysis ....................................................
57.504 Prevention Process Measures Monthly Monitoring for Dialysis ..........
57.505 Dialysis Patient Influenza Vaccination .................................................
57.506 Dialysis Patient Influenza Vaccination Denominator ...........................
57.507 Home Dialysis Center Practices Survey .............................................
200
1
40/60
133
200
700
700
7,200
7,200
7,200
7,200
1,730
615
615
430
400
100
5
1
12
30
30
12
50
5
1
40/60
40/60
40/60
127/60
5/60
25/60
10/60
75/60
10/60
10/60
30/60
53,333
46,667
2,333
15,240
7,200
90,000
14,400
25,950
5,125
513
215
Total ..........................................................................................................
........................
........................
........................
2,365,743
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–12809 Filed 6–12–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-20–1186]
Agency Forms Undergoing Paperwork
Reduction Act Review
jbell on DSKJLSW7X2PROD with NOTICES
Number of
responses per
respondent
Number of
respondents
Form No. & name
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Information
Collection for Tuberculosis Data from
Referring Entities to CureTB to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on December 23, 2019 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
VerDate Sep<11>2014
17:04 Jun 12, 2020
Jkt 250001
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Information Collection for
Tuberculosis Data from Referring
Entities to CureTB (OMB Control No.
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
0920–1186, Exp. 06/30/2020)—
Revision—National Center for Emerging
Zoonotic and Infectious Diseases
(NCEZID), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
CureTB at the Centers for Disease
Control and Prevention (CDC) works
with domestic and international
programs to protect the U.S. public by
preventing tuberculosis (TB) disease
transmission domestically and
internationally, as well as preventing
the development of drug resistant TB.
These goals are accomplished through
CureTB referral and continuity of care
services for mobile TB patients.
Lack of treatment adherence and
inappropriate selection of medications
are prime reasons for the continued
emergence and spread of resistant
strains of tuberculosis. To combat this,
CureTB ensures that patients
understand how to remain adherent to
treatment regimens, despite moving
between nations. CureTB also provides
information to the health care team that
will be continuing care about each
patient’s TB strain and tailored
medication regimen. CureTB gathers
demographic and clinical information
for each patient and connects that
individual to appropriate clinical care.
This information is also provided on a
real-time basis to medical providers and
public health authorities in receiving
nations so that follow-up with the
patient can be expedited.
The respondents are local health
departments (LHD) or Immigration and
Customs Enforcement (ICE) detention
centers within the United States and
foreign national TB programs or
healthcare facilities in other countries
that provide diagnostic and treatment
services to individuals affected by TB.
E:\FR\FM\15JNN1.SGM
15JNN1
36212
Federal Register / Vol. 85, No. 115 / Monday, June 15, 2020 / Notices
Individual TB patients may also be
respondents if critical clinical or contact
information is missing from their
referral and CureTB follows-up with
them to fill-in gaps to complete the
referral service. All 50 US states and
territories may refer TB patients to the
CureTB program. To date, CureTB has
also received referrals from Mexico and
Guatemala. Local health departments or
ICE detention facilities will submit
CureTB referral forms as they request
referral services. The number of referrals
varies widely between respondents.
To ensure adequate referral to
treatment occurs, CDC CureTB may
need to follow-up with an individual to
complete missing data fields concerning
clinical or contact information. This is
done to ensure continuity of care.
Therefore, individuals with TB are also
respondents in this information
collection. CDC’s CureTB program will
also continue working with our public
health partners in notifications and
referrals for contacts of TB cases. This
is a lesser used function of CureTB, but
burden is included below. These
respondents are health departments.
Finally, CDC staff in the CureTB
program also contact the new treating
physicians to determine patient
outcomes using CureTB Clinician Public
Health Department Follow-up Script.
The physicians are generally contacted
every two months over the course of
standard six month TB treatment, for a
total of three follow-up contacts per
patient.
The revision for this information
collection includes a small number of
changes to the CureTB Transnational
Notification information collection tool
for ease of use by the respondents, and
adding two pieces of additional data
important for clinical decision making
and patient contact. Additionally, CDC
is clarifying the specific burden
attributable to individuals within ICE
detention centers by noting this in the
Estimated Annualized Burden Hours
table. Finally, CDC is updating the
number of respondents and associated
burden based on program operations
over the last 12 months. No other
changes are proposed.
OMB approval is requested for three
years. Participation in this data
collection is voluntary. There are no
costs to respondents other than the time
required to complete the referral
documents and respond to CDC requests
for TB patient outcomes. The total
estimated annualized burden is 1,081
hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(in hours)
Form name
Local Health Departments (LHD) in the
United States.
TB patients referred by LHD ...........................
TB patients referred by ICE ............................
TB treating physicians in new country ............
CureTB Transnational Notification .................
70
4
30/60
CureTB Transnational Notification .................
CureTB Transnational Notification .................
Clinician Public Health Department Follow-up
Script.
CureTB Contact/Source Investigation (CI/SI)
Notification.
187
587
870
1
1
3
5/60
45/60
10/60
20
5
30/60
LHD in the United States ................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–12806 Filed 6–12–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–20–1193]
Agency Forms Undergoing Paperwork
Reduction Act Review
jbell on DSKJLSW7X2PROD with NOTICES
Number of
respondents
Type of respondents
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Assessment of
Technical Assistance and Training
Approaches to Accelerate
Comprehensive Cancer Control
Outcomes to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
VerDate Sep<11>2014
17:04 Jun 12, 2020
Jkt 250001
for Public Comment and
Recommendations’’ notice on December
6, 2019 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies’ estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
E:\FR\FM\15JNN1.SGM
15JNN1
]]>Agencies
[Federal Register Volume 85, Number 115 (Monday, June 15, 2020)]
[Notices]
[Pages 36211-36212]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-12806]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-20-1186]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Information Collection for Tuberculosis Data
from Referring Entities to CureTB to the Office of Management and
Budget (OMB) for review and approval. CDC previously published a
``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on December 23, 2019 to obtain comments from
the public and affected agencies. CDC did not receive comments related
to the previous notice. This notice serves to allow an additional 30
days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Information Collection for Tuberculosis Data from Referring
Entities to CureTB (OMB Control No. 0920-1186, Exp. 06/30/2020)--
Revision--National Center for Emerging Zoonotic and Infectious Diseases
(NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
CureTB at the Centers for Disease Control and Prevention (CDC)
works with domestic and international programs to protect the U.S.
public by preventing tuberculosis (TB) disease transmission
domestically and internationally, as well as preventing the development
of drug resistant TB. These goals are accomplished through CureTB
referral and continuity of care services for mobile TB patients.
Lack of treatment adherence and inappropriate selection of
medications are prime reasons for the continued emergence and spread of
resistant strains of tuberculosis. To combat this, CureTB ensures that
patients understand how to remain adherent to treatment regimens,
despite moving between nations. CureTB also provides information to the
health care team that will be continuing care about each patient's TB
strain and tailored medication regimen. CureTB gathers demographic and
clinical information for each patient and connects that individual to
appropriate clinical care. This information is also provided on a real-
time basis to medical providers and public health authorities in
receiving nations so that follow-up with the patient can be expedited.
The respondents are local health departments (LHD) or Immigration
and Customs Enforcement (ICE) detention centers within the United
States and foreign national TB programs or healthcare facilities in
other countries that provide diagnostic and treatment services to
individuals affected by TB.
[[Page 36212]]
Individual TB patients may also be respondents if critical clinical or
contact information is missing from their referral and CureTB follows-
up with them to fill-in gaps to complete the referral service. All 50
US states and territories may refer TB patients to the CureTB program.
To date, CureTB has also received referrals from Mexico and Guatemala.
Local health departments or ICE detention facilities will submit CureTB
referral forms as they request referral services. The number of
referrals varies widely between respondents.
To ensure adequate referral to treatment occurs, CDC CureTB may
need to follow-up with an individual to complete missing data fields
concerning clinical or contact information. This is done to ensure
continuity of care. Therefore, individuals with TB are also respondents
in this information collection. CDC's CureTB program will also continue
working with our public health partners in notifications and referrals
for contacts of TB cases. This is a lesser used function of CureTB, but
burden is included below. These respondents are health departments.
Finally, CDC staff in the CureTB program also contact the new
treating physicians to determine patient outcomes using CureTB
Clinician Public Health Department Follow-up Script. The physicians are
generally contacted every two months over the course of standard six
month TB treatment, for a total of three follow-up contacts per
patient.
The revision for this information collection includes a small
number of changes to the CureTB Transnational Notification information
collection tool for ease of use by the respondents, and adding two
pieces of additional data important for clinical decision making and
patient contact. Additionally, CDC is clarifying the specific burden
attributable to individuals within ICE detention centers by noting this
in the Estimated Annualized Burden Hours table. Finally, CDC is
updating the number of respondents and associated burden based on
program operations over the last 12 months. No other changes are
proposed.
OMB approval is requested for three years. Participation in this
data collection is voluntary. There are no costs to respondents other
than the time required to complete the referral documents and respond
to CDC requests for TB patient outcomes. The total estimated annualized
burden is 1,081 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Local Health Departments (LHD) in the CureTB Transnational 70 4 30/60
United States. Notification.
TB patients referred by LHD........... CureTB Transnational 187 1 5/60
Notification.
TB patients referred by ICE........... CureTB Transnational 587 1 45/60
Notification.
TB treating physicians in new country. Clinician Public Health 870 3 10/60
Department Follow-up
Script.
LHD in the United States.............. CureTB Contact/Source 20 5 30/60
Investigation (CI/SI)
Notification.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-12806 Filed 6-12-20; 8:45 am]
BILLING CODE 4163-18-P
